Lamellarins as Inhibitors of P‐Glycoprotein‐Mediated Multidrug Resistance in a Human Colon Cancer Cell Line

Chemical analysis of a Didemnum sp. (CMB‐01656) collected during scientific Scuba operations off Wasp Island, New South Wales, yielded five new lamellarins A1 ( 1 ), A2 ( 2 ), A3 ( 3 ), A4 ( 4 ) and A5 ( 5 ) and eight known lamellarins C ( 6 ), E ( 7 ), K ( 8 ), M ( 9 ), S ( 10 ), T ( 11 ), X ( 12 ) and χ ( 13 ). Analysis of a second Didemnum sp. (CMB‐02127) collected during scientific trawling operations along the Northern Rottnest Shelf, Western Australia, yielded the new lamellarin A6 ( 14 ) and two known lamellarins G ( 15 ) and Z ( 16 ). Structures were assigned to 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 on the basis of detailed spectroscopic analysis with comparison to literature data and authentic samples. Access to this unique library of natural lamellarins ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 ) provided a rare opportunity for structure–activity relationship (SAR) investigations, probing interactions between lamellarins and the ABC transporter efflux pump P‐glycoprotein (P‐gp) with a view to reversing multidrug resistance in a human colon cancer cell line (SW620 Ad300). These SAR studies, which were expanded to include the permethylated lamellarin derivative ( 17 ) and a series of lamellarin‐inspired synthetic coumarins ( 19 , 20 , 21 , 22 , 23 , 24 ) and isoquinolines ( 25 , 26 ), successfully revealed 17 as a promising new non‐cytotoxic P‐gp inhibitor pharmacophore.